Potentially Reversible Conditions in 1000 Consecutive Memory Clinic Patients
JNNP 73:390-394, Hejl,A.,et al, 2002
Reduced Incidence of AD with NSAID But Not H2 Receptor Antagonists
Neurol 59:880-886, Zandi,P.P.,et al, 2002
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
JAMA 288:1475-1483, Lyketsos,C.G.,et al, 2002
Adverse Long-term Effects of Brain Radiotherapy in Adult Low-grade Glioma Patients
Neurol 56:1285-1290,1255, Surma-aho,O.,et al, 2001
CSF Detection of the 14-3-3 Protein in Unselected Patients with Dementia
Neurol 56:1528-1533, Burkhard,P.R.,et al, 2001
Stem-Cell Research: Drawing the Line
Lancet 358:163,217, Greenberg,D.S., 2001
Return to Driving After Head Injury
JNNP 70:761-766, Hawley,C.A., 2001
Drugs for Alzheimer's Disease
BMJ 323:123-124, O'Brien,J.T . &Ballard,C.G., 2001
Fits and Strokes
Lancet 358:120, Sharma,P.,et al, 2001
Galantamine (Reminyl) for Alzheimer's Disease
Medical Letter 43:53-54, , 2001
Use of 14-3-3 and Other Brain-specific Proteins in CSF in the Diagnosis of Variant Creutzfeldt-Jakob Disease
JNNP 70:744-748, Green,A.J.E.,et al, 2001
Anosmia in Dementia is Associated with Lewy Bodies Rather Than Alzheimer's Pathology
JNNP 70:739-743,720, McShane,R.H.,et al, 2001
High-Dose Estradiol Improves Cognition for Women with AD, Results of a Randomized Study
Neurol 57:605-612, Asthana,S.,et al, 2001
Quantitation of 14-3-3 and Neurol-Specific Enolase Proteins in CSF in Creutzfeldt-Jakob Disease
Neurol 57:728-730, Aksamit,A.L.,et al, 2001
A 24-Week, Randomized, Double-Blind Study of Donepezil in Moderate to Severe Alzheimer's Disease
Neurol 57:613-620, Feldman,H.,et al, 2001
New Variant Creutzfeldt-Jakob Disease Presenting with Loss of Taste and Smell
JNNP 71:412-413, Reuber,M.&Al-Din,A.S.N., 2001
Positron Emission Tomography in Evaluation of Dementia
JAMA 286:2120-2127,2194, Silverman,D.H.S.,et al, 2001
Adult-Onset Leukoencephalopathy with Vanishing White Matter Presenting with Dementia
Ann Neurol 50:665-668, Prass,K.,et al, 2001
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
NEJM 345:1515-1521,1567, in 'T Veld,B.A.,et al, 2001
Current Concepts in Mild Cognitive Impairment
Arch Neurol 58:1985-1992, Petersen,R.C.,et al, 2001
Hypotension and Cognitive Impairment
Neurol 57:1986-1992,1945, Zuccala,G.,et al, 2001
Phenylketonuria Presenting in Adulthood as Progressive Spastic Paraparesis With Dementia
JNNP 71:795-797, Kasim,S.,et al, 2001
Influence of Leisure Activity on the Incidence of Alzheimer's Disease
Neurol 57:2236-2242, Scarmeas,N.,et al, 2001
Hormone Replacement Therapy and Reduced Cognitive Decline in Older Women
Neurol 57:2210-2216, Carlson,M.C.,et al, 2001
Magnetic Resonance Spectroscopy in AD
Neurol 56:592-598, Valenzuela,M.J.,et al, 2001
Is it Truly Dementia?
Lancet 357:684, Visvanatham,R., 2001
The Incidence of Mitochondrial Encephalomyopathies in Childhood: Clinical Features and Morphological, Biochemical, and DNA Abnormalities
Ann Neurol 49:377-383, Darin,N.,et al, 2001
Age-Related Memory Decline
Arch Neurol 58:360-364, Small,S.A., 2001
Evaluation of CSf-tau and CSF-AB42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice
Arch Neurol 58:373-379,349, Andreasen,N.,et al, 2001
Creutzfeldt-Jakob Disease: Serial Changes on Diffusion-Weighted MRI
J Comput Assist Tomogr 25:274-277, Matoba,M.,et al, 2001
Hormone Replacement Therapy and Cognition
JAMA 285:1489-1499, LeBlanc,E.S.,et al, 2001
Early Detection of Dementia: Mild Cognitive Impairment (an Evidence-based Review)
Neurol 56:1133-1142, 1131, Petersen,R.C.,et al, 2001
Neurodegenerative Diseases and Prions
NEJM 344:1516-1526,1548, Prusiner,S.B., 2001
Practice Parameter: Diagnosis of Dementia (an Evidence-Based Review)
Neurol 56:1143-1153, Knopman,D.S.,et al, 2001
Practice Parameter: Management of Dementia (an Evidence-Based Review)
Neurol 56:1154-1166, Doody,R.S.,et al, 2001
Neurologists' Use of ICD-9CM Codes for Dementia
Neurol 56:1206-1209, Pippenger,M.,et al, 2001
A Reevaluation of the Duration of Survival After the Onset of Dementia
NEJM 344:1111-1116, Wolfson,C.,et al, 2001
Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease
BMJ 322:841-844, Brown,P., 2001
HIV-associated Neurologic Disease Incidence Changes: Multicenter AIDS Cohort Study, 1990-1998
Neurol 56:257-260, Sacktor,N.,et al, 2001
Pathological Correlates of Late-Onset Dementia in a Multicentre, Community-based Population in England and Wales
Lancet 357:169-175, Neuroapthology Group of the Medical Research Counc, 2001
14-3-3 Protein Cerebrspinal Fluid Detection in Human Growth Hormone-Treated Creutzfeldt-Jakob Disease Patients
Ann Neurol 49:257-260, Brandel,J.,et al, 2001
Mesiotemporal T2-Weighted Hyperintensity: Neurosyphilis Mimicking Herpes Encephalitis
AJNR 22:314-316, Bash,S.,et al, 2001
Longitudinal Assessment of Neurocognitive Function After Coronary-Artery Bypass Surgery
NEJM 344:395-402,451, Newman,M.F.,et al, 2001
Effect of Donepezil on Brain Acetylcholineserase Activity in Patients with AD Measured by PET
Neurol 56:408-410, Shinotoh,H.,et al, 2001
The Effect of Brain Atrophy on Cerebral Hypometabolism in the Visual Variant of Alzheimer Disease
Arch Neurol 58:480-486, Bokde,A.L.W.,et al, 2001
Alien Hand Sign in Creutzfeldt-Jakob Disease
JNNP 68:103-104, Inzelberg,R.,et al, 2000
Diffusion-Weighted MR Imaging of the Brain
Radiology 217:331-345, Schaefer,P.W.,et al, 2000
De Novo Mutation in the Notch3 Gene Causing CADASIL
Ann Neurol 47:388-391, Joutel,A.,et al, 2000
A 5-Month, Randomized, Placebo-controlled Trial of Galantamine in AD
Neurol 54:2269-2276, Tariot,P.N.,et al, 2000
Galantamine in AD
Neurol 54:2261-2268, Raskind,M.A.,et al, 2000